TED
Clinical trials for TED explained in plain language.
Never miss a new study
Get alerted when new TED trials appear
Sign up with your email to follow new studies for TED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug could reduce bulging eyes in thyroid disease
Disease control OngoingThis study tests a drug called satralizumab for people with moderate-to-severe thyroid eye disease, a condition that causes eye bulging, double vision, and pain. About 131 participants will receive either the drug or a placebo to see if it reduces eye bulging by at least 2 millim…
Matched conditions: TED
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
New drug NTB003 tested in healthy people for first time
Knowledge-focused ENROLLING_BY_INVITATIONThis early-stage study tests the safety of a new drug called NTB003 in 40 healthy adults aged 25 to 45. Participants receive either the drug or a placebo to check for side effects and how the drug moves through the body. The goal is to gather safety information, not to treat any …
Matched conditions: TED
Phase: PHASE1 • Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC